Biblio
Involved-site radiotherapy is equally effective and less toxic than Involved-field radiotherapy in patients receiving combined modality treatment for early-stage unfavorable Hodgkin lymphoma - an analysis of the randomized phase III HD17 trial of the Germ. Int J Radiat Oncol Biol Phys. 2024.
Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9 editing. Stem Cell Res. 2024;77:103399.
.